Aspartoacylase (ASPA) Peptid
ASPA
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle ASPA Produkte
- ASPA (Aspartoacylase (ASPA))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- IKTSLAPLPC YVYLIEHPSL KYATTRSIAK YPVGIEVGPQ PQGVLRADIL
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ASPA antibody,
Alternative Names: ASPA control peptide, ASPA antibody Blocking Peptide, Anti-ASPA Blocking Peptide, Aspartoacylase Blocking Peptide, Canavan Disease Blocking Peptide, ACY2 Blocking Peptide, ASP Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- ASPA (Aspartoacylase (ASPA))
- Hintergrund
- ASPA catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.
- Molekulargewicht
- 36 kDa
-
Sie sind hier:
